Examkin

Soru

Zorluk: KolayMenstrual Cycle Abnormalities and Contraception

Match each patient's clinical profile with the most appropriate and safe contraceptive method according to the WHO Medical Eligibility Criteria.

  • 22-year-old with irregular menses and bothersome facial hairCombined oral contraceptive pill
  • 38-year-old who smokes 1.5 packs of cigarettes daily and requests a long-acting, hormone-free methodCopper intrauterine device
  • 28-year-old with heavy, painful periods and anemia who desires a highly effective, long-acting methodLevonorgestrel-releasing intrauterine device
  • 24-year-old breastfeeding mother at 3 weeks postpartum who prefers taking a daily medicationProgestin-only pill

Cevap

The 22-year-old with facial hair should receive the Combined oral contraceptive pill. The 38-year-old heavy smoker should receive the Copper intrauterine device. The 28-year-old with heavy periods should receive the Levonorgestrel-releasing intrauterine device. The 3-week postpartum breastfeeding mother should receive the Progestin-only pill.
Each contraceptive method precisely matches the patient's comorbidities and preferences. The combined oral contraceptive treats hyperandrogenism in PCOS. The copper IUD avoids the catastrophic cardiovascular risks of estrogen in older smokers. The levonorgestrel IUD directly treats heavy menstrual bleeding. The progestin-only pill safely provides daily contraception for early postpartum breastfeeding patients.

Adım Adım Çözüm

1
Evaluate the 22-year-old with hirsutism and irregular menses.
Recognize signs of polycystic ovary syndrome (PCOS).
Combined oral contraceptives are the preferred initial management to lower free androgens and regulate the cycle.
2
Evaluate the 38-year-old smoker.
Identify that age over 35 and smoking is an absolute contraindication to estrogen.
To provide long-acting, hormone-free contraception without cardiovascular risk, the Copper intrauterine device is selected.
3
Evaluate the 28-year-old with heavy, painful bleeding.
Identify the need for a method that provides excellent contraception while treating menorrhagia.
The Levonorgestrel-releasing intrauterine device thins the endometrium, drastically reducing menstrual blood loss.
4
Evaluate the breastfeeding mother at 3 weeks postpartum.
Identify that early postpartum status (<1 month) restricts the use of estrogen.
The Progestin-only pill provides safe, daily contraception that does not increase thromboembolism risk or interfere with milk supply.

Anahtar Kavram

Applying WHO Medical Eligibility Criteria to match contraceptive methods to specific clinical indications and contraindications.
Bu soruyu puanla

Konular

Menstrual Cycle Abnormalities and Contraception

Bu konudan daha fazla soru